CALAA-02

N/A

Report date: 2026/03/12 08:59:27
NME

Base Information

Drug NameCALAA-02
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionEndothelial PAS domain-containing protein 1 inhibitorsRNA interference
TargetsEndothelial PAS domain-containing protein 1
Therapy Area/IndicationsNeuroblastomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCalando PharmaceuticalsNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCalando PharmaceuticalsNational Cancer Institute
Active IndicationsN/A
Inactive IndicationsNeuroblastomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A